People with Parkinson’s disease (PD), a neurodegenerative disorder that destroys dopamine-producing nerve cells in the brain, can also benefit from Dihexa supplementation. Studies show that this powerful nootropic can help combat PD through various mechanisms:
Dihexa can help treat PD symptoms by augmenting synaptic connectivity via the formation of new functional synapses.
Activation of the HGF/c-Met system by Dihexa stimulates protection and restoration of neurons in the brain.
In patients with PD, HGF promoted the survival and migration of immature neurons in the brain.
In a PD lesion model, Dihexa administration improved behavioral deficits.
Gene transfer of human hepatocyte growth factor in a rodent model of PD prevented neuronal death, suggesting that Dihexa activation of HGF can be a potential novel therapy for PD.
Dihexa along with Angiotensin IV can prevent the progression of PD by increasing the production of dopamine.